Suchergebnisse - "Bergot, Emmanuel"

PubPharm (6)

1

Contribution of the IdyllaTM System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations

enthalten in: Current oncology (Toronto, Ont.) | 2021

von Petiteau, C. | Robinet-Zimmermann, G. | Riot, A. | +8

2

Tyrosine kinase inhibitors in pulmonary arterial hypertension : a double-edge sword?

enthalten in: Seminars in respiratory and critical care medicine | 2013

von Godinas, L. | Guignabert, C. | Seferian, A. | +5

3

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von de Fraipont, F. | Levallet, G. | Creveuil, C. | +118

4

A STEPP too far for FLEX?

enthalten in: The Lancet. Oncology | 2012

von Bergot, E. | Creveuil, C. | Zalcman, G.

CommentOn: Lancet Oncol. 2012 Jan;13(1):33-42. - PMID 22056021

5

Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers : Methodological issues

enthalten in: Presse medicale (Paris, France : 1983) | 2011

von Bergot, E. | Levallet, G. | Creveuil, C. | +2

6

Gefitinib plus docetaxel in non-small-cell lung cancer

enthalten in: Lancet (London, England) | 2009

von Zalcman, G. | Bergot, E.

CommentOn: Lancet. 2008 Nov 22;372(9652):1809-18. - PMID 19027483

1
[1]